26-A-15539-ACC ASSESSMENT OF GASTROINTESTINAL (GI) BLEEDING VIA FECAL HEMOGLOBIN ANALYSIS AFTER TREATMENT WITH ANTIBODIES TARGETING FACTOR XI VERSUS RIVAROXABAN ON TOP OF BACKGROUND ASPIRIN: RESULTS FROM A PHASE 1 STUDY